ONKOLOGISK FORUM
Trondheim November 20.-21.
MAIN PROGRAM 2025
THURSDAY NOVEMBER 20th
Turid Lund, St Olavs Hospital and Petter Brandal, Oncology Forum Board
09:00 - 09:10 Opening
09:10 - 09:50 Patient Centered Care - How does it fit into todays Oncology Practice?
Camilla Zimmermann, Princess Margaret Cancer Centre, Toronto, Canada
09:50 - 10:10 An innovative solution to support efficient Shared Decision Making
Stein Kaasa, Oslo University Hospital
10:10 - 10:25 Tumor-oriented therapy in the last phase for lung cancer patients
Yngvar Nilssen, The Cancer Registry of Norway
10:25 - 10:50 Coffee break
10:50 - 11:20 Novel Antibody Drug Conjugates In Gynecologic Oncology - From Bench to Bedside
Gottfried E. Konecny, David Geffen School of Medicine, University of California, USA
11:20 - 11:45 King Olav V's Cancer Research Award 2025
Karl-Johan Malmberg, Oslo University Hospital
11:45 - 12:00 When everyone is an expert - how to secure that patients receive reliable and correct information.
Ole Alexander Opdalshei, Cancer Society
12:00 - 13:30 Lunch/exhibition
13:30 - 17:30 Parallell sessions for the National Diagnose Cancer Groups
Norsk Bryst Cancer Gruppe (NBCG)
Norsk Gastrointestinal Cancer gruppe (NGICG)
Norsk Lunge Cancer gruppe (NLCG)
Norsk Lymfom Gruppe/ Hematologi
Norsk Forening for Gynekologisk Kreft (NFGO)
Norsk Nevro Onkologi
Norsk Forening for Palliativ medisin (NFPM)
Norsk Gruppe for Hode Hals Cancer
Norsk Sarkomgruppe
Norsk Urologisk Cancer Gruppe (NUCG)
Nasjonal Kompetansetjenste for seneffekter etter kreftbehandling
19:30 Dinner
FRIDAY NOVEMBER 21st
09:00 - 09:40 Dentist Olaf Aase and wife memorial lecture
Implementation strategies for I-PREDICT
Razelle Kurzrock, Medical College of Wisconsin, USA
09:40 - 10:10 Precision oncology in breast cancer by targeting ESR1 mutations early: SERENA-6” findings from PADA-1 and SERENA-6
Francois-Clement Bidard, Institut Curie, Paris
10:10 - 10:30 IMPRESS Norway - Status and results
Åslaug Helland, Oslo University Hospital
10:30 - 11:00 Coffee break
11:00 - 11:20 Functional profiling in oncology
Kjetil Taskén, Oslo University Hospital
11:20 - 11:40 New treatments and mechanisms in precision medicine
Åsmund Flobak, NTNU, St. Olavs Hospital
11:40 - 11:55 DMP - Approval of drugs in the EMA system
Ingrid Wang, Directorate for medical products
11:55 - 12:10 Procurement of patented oncology drugs
Martin Haugrud Kastnes, Hospital purchase
12:10 - 12:25 Oncological Forum Career Scholarship 2025
12:25 - 13:30 Lunch/exhibition
13:30 - 13:55 Impact of Real-World Data on Clinical Treatment Guidelines for Immunotherapy
Marco Donia, Copenhagen University Hospital, Herlev, Denmark
13:55 - 14:20 Less is more: De-escalation strategies in patient management and clinical trials
Benjamin Besse, Gustave Roussy, Université Paris-Saclay, France
14:20 - 14:45 Doubling the number of cancer patients in clinical studies - is it realistic?
Bjørn Henning Grønberg, NTNU, St. Olavs Hospital
14:45 - 14:55 Is there a study for my patient? An app to help for study enclosure
Odd Terje Brustugun, Siri Bråthen, Vestre Viken, Drammen Hospital
14:55 - 15:00 Conclusions
